Cite
HARVARD Citation
Hennermann, J. et al. (2019). Pharmacokinetics, pharmacodynamics, and safety of moss‐aGalactosidase A in patients with Fabry disease. Journal of inherited metabolic disease. 42 (3), pp. 527-533. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hennermann, J. et al. (2019). Pharmacokinetics, pharmacodynamics, and safety of moss‐aGalactosidase A in patients with Fabry disease. Journal of inherited metabolic disease. 42 (3), pp. 527-533. [Online].